Reproductive factors, glutathione S-transferase M1 and T1 genetic polymorphism and breast cancer risk

Breast Cancer Research and Treatment

Volumn 78, Issue 1, 2003, Pages 89-96

  Park, Sue Kyung ^a   Kang, Daehee ^b   Noh, Dong Young ^b   Lee, Kyoung Mu ^b   Kim, Sook Un ^b   Choi, Ji Yeob ^b   Choi, In Mi ^b   Ahn, Se Hyun ^c   Choe, Kuk Jin ^b   Hirvonen, Ari ^d   Strickland, Paul T ^e   Yoo, Keun Young ^b  

^a Konkuk University School of Medicine   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c University of Ulsan College of Medicine   (South Korea)

^d FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Breast cancer; Genetic polymorphisms; GSTM1; GSTT1; Interaction; Reproductive factor

Indexed keywords

GLUTATHIONE TRANSFERASE;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HIGH RISK POPULATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; NULL ALLELE; NULLIPARA; PARITY; POLYMERASE CHAIN REACTION; PREGNANCY; PREMENOPAUSE; PRIORITY JOURNAL; STATISTICAL MODEL;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; CLIMACTERIC; FEMALE; GLUTATHIONE TRANSFERASE; HUMANS; PARITY; POLYMORPHISM, GENETIC; REPRODUCTION; RISK;

EID: 0037369033     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022113713226     Document Type: Article

References (30)

1. Farbers JF: The incidence of breast cancer: the global burden, public health considerations. Semin Oncol 24(Suppl 1): S1-S20, 1997
2. The Korean Breast Cancer Society: Clinical characteristics of Korean breast cancer patients in 1998. J Kor Med Sci 15: 569-579, 2000
3. Madigan MO, Ziegler RG, Benichou J, Byrne C, Hoover RN: Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst 87: 1681-1685, 1995
4. Davis DL, Bradlow HL, Wolff M, Woodruff T, Hoel DG, Anton-Culver H: Medical hypothesis: xenoestrogens as preventable causes of breast cancer. Environ Health Perspect 101: 372-377, 1993
5. Coughlin SS, Piper M: Genetic polymorphisms and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 8: 1023-1032, 1999
6. Dunning AM, Healey CS, Pharoah PDP, Teare MD, Ponder BAJ, Easton DF: A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomar Prev 8: 843-854, 1999
7. Ketterer B: The protective role of glutathione and glutathione transferases in mutagenesis and carcinogenesis. Mutat Res 202: 343-361, 1988
8. Cavalieri EL, Stack DE, Debanesan PD, Todorovic R, Dwivedy L, Higginbotham S, Johansson SL, Patil KD, Gross ML, Gooden JK, Ramanathan R, Cerny RL, Rogan EG: Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc Natl Acad Sci USA 94: 10937-10942, 1997
9. Awashi YC, Zimniak P, Awashi S, Singhal SS, Srivastava SK, Piper JT, Chaubey M, Petersen DR, He NG, Sharma R, Singh S, Khan MF, Ansari GAS, Boor PJ: A new group of glutathione S-transferase with a protective role against lipid peroxidation. In: Vermeulen MPE (ed), Glutathione S-transferases: Structure, Function and Clinical Implications. Taylor & Francis, London, 1996, pp 111-124
10. Park SK, Yoo KY, Lee SJ, Kim SU, Ahn SH, Noh DY, Choe KJ, Strickland PT, Hirvonen A, Kang DH: Alcohol consumption, glutathione S-transferase M1 and T1 genetic polymorphisms and breast cancer risk. Pharmacogenetics 10: 1-9, 2000
11. Bell DA, Taylor JA, Paulson DF, Robertson CN, Mohler JL, Lucier GW: Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst 85: 1159-1164, 1993
12. Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, Ketterer B, Taylor JB: Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 300 (Pt 1): 271-276, 1994
13. Chen H, Sandler DP, Taylor JA, Shore DL, Liu E, Bloomfield CD, Bell DA: Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect. Lancet 347: 295-297, 1996
14. Breslow NE, Day NE: Statistical Methods in Cancer Research. Vol 1, The Analysis of Case-Control Studies. IARC Scientific Publications No. 32, Lyon, 1980
15. Schlesselman JJ: Case-control studies. Design, Conduct, Analysis. Oxford University Press, New York, 1982
16. Ames BN: Dietary carcinogens and anticarcinogens: oxygen radicals and degenerative diseases. Science 221: 1256-1264, 1983
17. Wright RM, McManaman JL, Repine JE: Alcohol-induced breast cancer: a proposed mechanism. Free Radical Biol Med 26: 348-354, 1999
18. Zhu BT, Conney AH: Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 12: 1-27, 1998
19. Service RF: New role for estrogen in cancer? Science (Washington, DC) 279: 1631-1633, 1998
20. Lerhr JG: Genotoxicity of the steroidal oestrogens oestrone and oestradiol: possible mechanism of uterine and mammary cancer development. Hum Reprod Update 7(3): 273-281, May-June, 2001
21. Yager JD: Endogenous estrogens as carcinogens through metabolic activation. J Natl Cancer Inst Monogr (27): 67-73, 2000
22. Yager JD, Liehr JG: Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol 36: 203-232, 1996
23. Pike MC, Kralio MD, Henderson BE, Casagrande JT, Hoel DG: Hormonal risk factors, breast tissue age and the age-incidence of breast cancer. Nature 303: 767-770, 1983
24. Maugard C, Charrier J, Bignon YJ: Allelic deletion at glutathione S-transferase M1 locus and its association with breast cancer susceptibility. Chemico-biol Interact 111-112: 365-375, 1998
25. Bailey LR, Roodi CS, Verrier CS, Yee CJ, Dopont WD, Parl FF: Breast cancer and CYPIA1, GSTM1, and GSTT1 polymorphisms: evidence of a lack of association in Caucasians and African Americans. Cancer Res 58: 65-70, 1998
26. Helzlsouer KJ, Sekmin O, Huang HY, Strickland PT, Hoffman S, Alberg AJ, Watson M, Comstock GW, Bell D: Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer. J Natl Cancer Inst 90: 513-518, 1998
27. Hankinson SE, Colditz GA, Hunter DJ, Manson JE, Willett WC, Stampfer MJ, Longcope C, Speizer FE: Reproductive factors and family history of breast cancer in relation to plasma estrogen and prolactin levels in postmenopausal women in the Nurses Health Study (United States). Cancer Cause Contr 6: 217-224, 1995
28. Gao YT, Shu XO, Dai Q, Brinton LA, Wen W, Sellers TA, Kushi LH, Ruan Z, Bostick RM, Jin F, Zheng W: Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai Breast Cancer Study. Int J Cancer 87: 295-300, 2000
29. Huang CS, Chern HD, Chang KJ, Cheng CW, Hsu SM, Shen CY: Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYPI7, CYPIA1, and COMT: a multigenic study on cancer susceptibility. Cancer Res 59: 4870-4875, 1999
30. Henderson BE, Pike MC, Bernstein L, Ross RK: Chap 47. Breast cancer. In: Schottenfeld D, Fraumeni Jr JF (eds) Cancer Epidemiology and Prevention. 2nd edn, Oxford University Press, New York, 1996, pp 1025-1026